Intended for healthcare professionals

Letters Initial drug treatment in Parkinson’s disease

Reboxetine has no antidepressant effect at all

BMJ 2015; 351 doi: (Published 03 November 2015) Cite this as: BMJ 2015;351:h5842
  1. Richard Braithwaite, consultant psychiatrist1
  1. 1St Mary’s Hospital, Newport PO30 5TG, UK
  1. richard.braithwaite{at}

Muzerengi and Clarke are correct to advise against the use of most antidepressants in combination with the monoamine oxidase B inhibitors, rasagiline and selegiline.1 But it …

View Full Text

Log in

Log in through your institution


* For online subscription